Cargando…
An activist's argument that participant values should guide risk–benefit ratio calculations in HIV cure research
The patient empowerment movement, spurred by AIDS activism in the 1980s, quickly evolved to encompass how study participants are considered and treated in clinical research. Initially, people fearing death of AIDS sought early access to experimental medications that had not undergone rigorous testin...
Autor principal: | Evans, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293856/ https://www.ncbi.nlm.nih.gov/pubmed/28062651 http://dx.doi.org/10.1136/medethics-2015-103120 |
Ejemplares similares
-
For love and money: the need to rethink benefits in HIV cure studies
por: Largent, Emily
Publicado: (2017) -
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
por: Kumar, Rahul
Publicado: (2017) -
The social value of candidate HIV cures: actualism versus possibilism
por: Brown, Regina, et al.
Publicado: (2017) -
Must research benefit human subjects if it is to be permissible?
por: Wikler, Daniel
Publicado: (2017) -
Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program
por: Conaghan, Philip G., et al.
Publicado: (2021)